课题基金 / 基金详情

Total synthesis of the cylindrospermopsin alkaloids

Total synthesis of the cylindrospermopsin alkaloids
圆柱精蛋白生物碱的全合成
批准号:
EP/J01821X/1
负责人:
Patrick Murphy
金额:
$23.53万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2012
资助国家:
英国
项目状态:
已结题
起止时间:
2012 至 --

项目摘要

项目成果

Patrick Murphy的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The proposed research is concerned with the synthesis of a family of naturally occurring marine natural products namely cylindrospermopsin , 7-epi-cylindrospermopsin and 7-deoxy-cylindrospermopsin, which are found in several species of blue-green algae. Cylindrospermopsin was originally isolated from a bloom of Cylindrospermopsis raciborskii after an outbreak of a mystery disease on Palm Island in Queensland, Australia. Its unique structure, consisting of uracil ring and a zwitterionic guanidinium/sulfate combination imparts very high water solubility and it is this property which poses a potential threat to water supplies. The biological activity of cylindrospermopsin centers on its toxicity to liver and kidney tissue, its ability to inhibit protein synthesis as well as being able to covalently modify both DNA and RNA. Synthetic efforts toward the natural product have been reported by other groups using linear and convergent strategies, however overall yields for these are generally low (0.2-2% yield) and require a considerable number of operations (19-36 steps)The goal of this project is to develop our already proven approach to a model of the metabolites into a total synthesis of the three molecules via a synthesis mimicking that found in nature (biomimetic). This methodology is convergent in nature and will be shorter than any other reported previously, thus being flexible enough to enable the rapid preparation of the three metabolites. In addition to this, it is hoped that a flexible and rapid method for the preparation of synthetic analogues will emerge from this methodology, enabling the study of the biological mode of action of these compounds. This in turn will lead to an understanding of the structural requirements for biological action and the potential for preparing less toxic analogues, which retain the required activity.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3987/com-20-14236
发表时间: 2020-04-01
期刊: HETEROCYCLES
影响因子: 0.6
作者: [Ashworth, Zackary J. R., Bartholomew, Barbara, Murphy, Patrick J.]
通讯作者: Murphy, Patrick J.
DOI: 10.1039/c4ra03031a
发表时间: 2014
期刊: RSC Adv.
影响因子: --
作者: [Evans D]
通讯作者: Evans D
DOI: 10.1039/c9ra07508a
发表时间: 2020-06-10
期刊: RSC ADVANCES
影响因子: 3.9
作者: [Al-Taie, Zahraa S., Anetts, Simon R., Christensen, Jeppe, Coles, Simon J., Horton, Peter N., Evans, Daniel M., Jones, Leigh F., de Kleijne, Frank F. J., Ledbetter, Shaun M., Mehdar, Yassin T. H., Murphy, Patrick J., Wilson, Jack A.]
通讯作者: Wilson, Jack A.
Iodocyclisations reactions of Boc- and Cbz-protected N-allylguanidines
Boc 和 Cbz 保护的 N-烯丙基胍的碘环化反应
DOI: 10.1016/j.tet.2014.03.087
发表时间: 2014
期刊: Tetrahedron
影响因子: 2.1
作者: [Al Shuhaib Z]
通讯作者: Al Shuhaib Z
7
    MRI: Acquisition of an FPLC Liquid Chromatography System for Use in Biomolecule Purification, Protein Analysis, and Research Training at Seattle University
    • 批准号:
      0923580
    • 项目类别:
      Standard Grant
    • 资助金额:
      $12.96万
    • 财政年份:
      2009
    • 负责人:
      Patrick Murphy
    • 依托单位:
    国内基金
    海外基金
    胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
    • 批准号:
      82370976
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      郑凌艳
    • 依托单位:
    “肠—肝轴”PPARα/CYP8B1胆汁酸合成信号通路在减重手术改善糖脂代谢中的作用与机制
    • 批准号:
      82370902
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      田景琰
    • 依托单位:
    lncGEI诱导湖羊卵巢颗粒细胞E2合成的分子机制
    • 批准号:
      32372856
    • 项目类别:
      面上项目
    • 资助金额:
      50.00万元
    • 批准年份:
      2023
    • 负责人:
      李隐侠
    • 依托单位:
    脂肪酸合成通过GDF15/IRS2介导胰岛素抵抗促进血管内皮细胞活化导致脓毒症肺损伤的机制研究
    • 批准号:
      82372203
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      李然然
    • 依托单位: